LYRA THERAPEUTICS INC (LYRA) Stock Analyst Ratings
USA - NASDAQ:LYRA - US55234L2043 - Common Stock
5.62 USD
+0.17 (+3.21%)
ChartMill assigns a Buy % Consensus number of 49% to LYRA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 23.46. This target is 317.44% above the current price.
LYRA was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about LYRA.
In the previous month the buy percentage consensus was at a similar level.
LYRA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-06-10 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-07 | Jefferies | Downgrade | Buy -> Hold |
| 2024-05-07 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-05-06 | BTIG | Downgrade | Buy -> Neutral |
| 2024-05-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-25 | B of A Securities | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-12 | B of A Securities | Maintains | Buy -> Buy |
| 2023-08-31 | HC Wainwright & Co. | Initiate | Buy |
| 2023-02-07 | BTIG | Maintains | Buy |
| 2022-05-24 | Cantor Fitzgerald | Initiate | Overweight |
LYRA THERAPEUTICS INC / LYRA FAQ
What is the price target for LYRA stock?
9 analysts have analysed LYRA and the average price target is 23.46 USD. This implies a price increase of 317.44% is expected in the next year compared to the current price of 5.62.
What is the consensus rating for LYRA stock?
The consensus rating for LYRA THERAPEUTICS INC (LYRA) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.